Chronic hepatitis B therapeutic sales share among 8 major markets

Published by Statista Research Department, Jan 1, 2016
This statistic shows the comparison of the share of hepatitis B therapeutic sales among eight major markets in 2014 and 2024. China's share among the global eight major markets for chronic hepatitis B therapeutics was some 39 percent in 2014, and it is predicted to increase to over 47 percent in 2024.

Share of chronic hepatitis B therapeutic sales among 8 major markets in 2014 and 2024

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2016

Region

Worldwide

Survey time period

as of January 2016

Supplementary notes

All data is based on primary research interviews and surveys conducted with KOLs and high-prescribing physicians in the countries included in this report.
* Forecast

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Top pharmaceutical drugs "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Top pharmaceutical drugs

Global overview

3

Top companies' top products

5

Best-selling drugs

7

U.S. overview

5

Outlook

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

OTC medicines in the UK
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu